BiotechTube
Home/Pipeline/HS370

HS370

Heart Failure, Obesity

PreclinicalActive

Key Facts

Indication
Heart Failure, Obesity
Phase
Preclinical
Status
Active
Company
35Pharma

About 35Pharma

35Pharma creates multi‑specific Activin/GDF ligand traps to treat high‑unmet‑need cardiometabolic and pulmonary diseases.

View full company profile

Therapeutic Areas

Pulmonary HypertensionHeart FailureObesity